Literature DB >> 25049375

Minor amputation and palliative wound care as a strategy to avoid major amputation in patients with foot infections and severe peripheral arterial disease.

Neal R Barshes1, Benjamin Gold2, Aimee Garcia2, Carlos F Bechara2, George Pisimisis2, Panos Kougias2.   

Abstract

Foot infections occurring in patients with severe peripheral arterial disease (PAD) who are not considered candidates for revascularization and limb salvage efforts are generally treated with major amputations. Herein we describe our early experiences in managing foot infections with minor amputations and palliative wound care as a strategy to avoid the functional disability often associated with major amputations. Patients with severe PAD that underwent minor amputations and subsequent palliative wound care for moderate/severe infections were paired with age-matched controls with PAD that underwent primary major amputations for foot infections. Eleven patients who underwent minor amputations and palliative wound care of 13 limbs were compared to an age-matched cohort of 12 patients undergoing 13 major amputations.The median age was 80 years in both groups. Survival at 1 and 2 years did not differ significantly between groups. All patients who were ambulatory and/or independently living remained so following palliative management; in contrast, major amputation changed ambulatory status in 75% of patients and independent living status in 50%. Palliative management did not result in ascending/systemic sepsis or progressive necrosis. The need for reoperations was uncommon in both groups. In summary, minor amputations and operative drainage with subsequent palliative wound care appears to be a safe management option in patients with severe PAD and moderate or severe foot infections that are not candidates for revascularization. Palliative management may result in less functional impairment than major amputation.
© The Author(s) 2014.

Entities:  

Keywords:  diabetic foot infection; palliative care

Mesh:

Year:  2014        PMID: 25049375     DOI: 10.1177/1534734614543663

Source DB:  PubMed          Journal:  Int J Low Extrem Wounds        ISSN: 1534-7346            Impact factor:   2.057


  6 in total

1.  Expression of TGF-β1 and miRNA-145 in patients with diabetic foot ulcers.

Authors:  Fengmei Zhang; Yuguo Ren; Peng Liu; Yufeng Ren; Debao Wang
Journal:  Exp Ther Med       Date:  2016-03-02       Impact factor: 2.447

Review 2.  2016 AHA/ACC Guideline on the Management of Patients With Lower Extremity Peripheral Artery Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines.

Authors:  Marie D Gerhard-Herman; Heather L Gornik; Coletta Barrett; Neal R Barshes; Matthew A Corriere; Douglas E Drachman; Lee A Fleisher; Francis Gerry R Fowkes; Naomi M Hamburg; Scott Kinlay; Robert Lookstein; Sanjay Misra; Leila Mureebe; Jeffrey W Olin; Rajan A G Patel; Judith G Regensteiner; Andres Schanzer; Mehdi H Shishehbor; Kerry J Stewart; Diane Treat-Jacobson; M Eileen Walsh
Journal:  Circulation       Date:  2016-11-13       Impact factor: 29.690

3.  Heel Wounds Predict Mortality but Not Amputation after Infrapopliteal Revascularization.

Authors:  Abhisekh Mohapatra; Jon C Henry; Efthimios D Avgerinos; Rabih A Chaer; Steven A Leers; Aureline Boitet; Michael J Singh; Eric S Hager
Journal:  Ann Vasc Surg       Date:  2018-03-06       Impact factor: 1.466

Review 4.  Role of miRNAs in diabetic neuropathy: mechanisms and possible interventions.

Authors:  Prabhsimran Kaur; Sushil Kotru; Sandeep Singh; Anjana Munshi
Journal:  Mol Neurobiol       Date:  2022-01-13       Impact factor: 5.590

5.  Population-Based Trends in Amputations and Revascularizations for Peripheral Artery Disease From 1990 to 2009.

Authors:  Jeffrey J Nienaber; Carin Y Smith; Stephen Cha; Mateus Correa; Phillip G Rowse; Kent R Bailey; Manju Kalra
Journal:  Mayo Clin Proc       Date:  2022-02-15       Impact factor: 11.104

6.  Deferring Amputation in Diabetic Foot Osteomyelitis: Doing More Harm Than Good?

Authors:  Shiwei Zhou; Brian M Schmidt; Oryan Henig; Keith S Kaye
Journal:  Open Forum Infect Dis       Date:  2021-04-14       Impact factor: 3.835

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.